Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot suit aims to get kids with disabilities walking

NCT ID NCT07159360

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a robotic exoskeleton called CLINICAL EXPLORER in 60 children aged 2 to 17 with neurodevelopmental disorders like cerebral palsy. The device supports walking during 8 therapy sessions. Researchers will check if it is safe, easy to use, and helps improve movement and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CLINICAL EXPLORER robotic gait exoskeleton
What this could lead to
If successful, this exoskeleton could provide a safe and effective way to improve walking ability and quality of life for children with conditions like cerebral palsy.
What could go wrong
This is an early-stage study with only 60 participants, focused on safety and usability. The device may not work for all children, and there is a risk of falls or skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 to 17 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Phase 0 * Age between 2 and 17 years. * Consent from the participant or legal guardian to participate in the study. * No diagnosis of neurodevelopmental disorders such as CP, NMD, LM, or MS. Inclusion Criteria for Phase 1 * Age between 2 and 17 years. * Consent from the participant or legal guardian to participate in the study. * Diagnosis of neurodevelopmental disorders such as CP, NMD, LM, or MS. Inclusion Criteria Related to the EXPLORER CLINICAL Device Characteristics * Medical authorization to stand upright and perform weight-bearing gait training. * Weight less than or equal to 60 kg. * Hip width less than or equal to 40 cm. * Distance from the hip joint center to the knee joint center: 21 cm - 36 cm. * Distance from the knee joint center to the ankle joint center: 20 - 35 cm. * EU shoe size less than or equal to 40. Exclusion Criteria: * Any medical contraindication for standing or walking. * Presence of non-reducible contractures or heterotopic ossification above the degrees allowed by the device and/or outside the trajectory imposed by the device. * Spasticity (MAS) = 4 in lower limbs at the time of device use. * Structured hip and/or knee contracture greater than 20 degrees. * Inability to stand or walk with more than 5 degrees of hip abduction. * Inability to achieve 5 degrees of dorsal ankle flexion from the neutral position with or without orthosis. * Tibial leg length discrepancy that cannot be mitigated with the use of a foot wedge. * Skin alterations in areas of contact with the device. * History of fracture without trauma. * Presence of other conditions that cause exercise intolerance (such as uncontrolled hypertension, coronary artery diseases, arrhythmia, congestive heart failure, severe pulmonary disease). * Behavioral disorders that interfere with proper use of the device, such as impulsivity. * Allergy to any of the materials of the EXPLORER CLÍNICO: cotton, nylon, polyester, PPS, PEEK, or ABS. The materials used in EXPLORER CLÍNICO that were not previously used in ATLAS 2030, a medical device certified by the AEMPS, are PPS, PEEK, and ABS.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Leukodystrophy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Asociación Pro Personas con Paralisis Cerebral (APAC-IAP)

    Mexico City, Mexico City, 06720, Mexico

  • Hospital Infantil Universitario Niño Jesús-Servicio de Neuro Ortopedia

    Madrid, Madrid, 28009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.